These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29053231)

  • 1. Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: A randomized clinical trial.
    Guzman CB; Dulude H; Piché C; Rufiange M; Sadoune AA; Rampakakis E; Carballo D; Triest M; Zhang MX; Zhang S; Tafreshi M; Sicard E
    Diabetes Obes Metab; 2018 Mar; 20(3):646-653. PubMed ID: 29053231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes.
    James DE; Shen T; Geiser JS; Garhyan P; Chigutsa E
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; 13(7):1214-1223. PubMed ID: 38736200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
    Kollar C; Schneider H; Waksman J; Krusinska E
    Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
    Loose I; Winkel M
    Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
    Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
    Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study.
    Matsuhisa M; Takita Y; Nasu R; Nagai Y; Ohwaki K; Nagashima H
    Diabetes Obes Metab; 2020 Jul; 22(7):1167-1175. PubMed ID: 32115879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
    Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.
    Meltzer EO; Ratner PH; McGraw T
    J Allergy Clin Immunol Pract; 2015; 3(5):702-8. PubMed ID: 26143019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antihistamine-decongestant-analgesic combinations for the common cold.
    De Sutter AI; Eriksson L; van Driel ML
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD004976. PubMed ID: 35060618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
    Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
    Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
    Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM
    Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.
    Seaquist ER; Dulude H; Zhang XM; Rabasa-Lhoret R; Tsoukas GM; Conway JR; Weisnagel SJ; Gerety G; Woo VC; Zhang S; Carballo D; Pradhan S; Piché CA; Guzman CB
    Diabetes Obes Metab; 2018 May; 20(5):1316-1320. PubMed ID: 29504662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging reveals the complementary effects of decongestant and Breathe Right Nasal Strips on internal nasal anatomy.
    Bishop CA; Johnson SM; Wall MB; Janiczek RL; Shanga G; Wise RG; Newbould RD; Murphy PS
    Laryngoscope; 2016 Oct; 126(10):2205-11. PubMed ID: 26865420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold.
    Jawad SS; Eccles R
    Rhinology; 1998 Jun; 36(2):73-6. PubMed ID: 9695162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon nasal powder (Baqsimi) for severe hypoglycemia.
    Med Lett Drugs Ther; 2019 Sep; 61(1581):148-149. PubMed ID: 31599866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.